Plantaricin Nc8 Alpha Beta Prevents Staphylococcus Aureus-Mediated Cytotoxicity And Inflammatory Responses Of Human Keratinocytes

Multidrug resistance bacteria constitue an increasing global health problem and the development of novel therapeutic strategies to face this challenge is urgent. Antimicrobial peptides have been proven as potent agents against pathogenic bacteria shown by promising in vitro results. The aim of this study was to characterize the antimicrobial effects of PLNC8 alpha beta on cell signaling pathways and inflammatory responses of human keratinocytes infected with S. aureus. PLNC8 alpha beta did not affect the viability of human keratinocytes but upregulated several cytokines (IL-1 beta, IL-6, CXCL8), MMPs (MMP1, MMP2, MMP9, MMP10) and growth factors (VEGF and PDGF-AA), which are essential in cell regeneration. S. aureus induced the expression of several inflammatory mediators at the gene and protein level and PLNC8 alpha beta was able to significantly suppress these effects. Intracellular signaling events involved primarily c-Jun via JNK, c-Fos and NF kappa B, suggesting their essential role in the initiation of inflammatory responses in human keratinocytes. PLNC8 alpha beta was shown to modulate early keratinocyte responses, without affecting their viability. The peptides have high selectivity towards S. aureus and were efficient at eliminating the bacteria and counteracting their inflammatory and cytotoxic effects, alone and in combination with low concentrations of gentamicin. We propose that PLNC8 alpha beta may be developed to combat infections caused by Staphylococcus spp.